HIF-1 alpha then elicited the transcriptional activation of VEGF, a HIF-1 alpha target gene, suggesting that implantable 3D bioprinted scaffolds loaded with drugs can aid in the repair of endothelial cells in cardiovascular disease [224]. This evidence concerns the gene VEGFA and cardiovascular disorder.